Impact of young age on treatment efficacy and safety in advanced colorectal cancer: a pooled analysis of patients from nine first-line phase III chemotherapy trials.
about
Benefits of remote real-time side-effect monitoring systems for patients receiving cancer treatmentSymptom burden among young adults with breast or colorectal cancerDoes young age influence the prognosis of colorectal cancer: a population-based analysis.The prognostic significance of age in operated and non-operated colorectal cancer.Progression-free Survival Decreases with Each Subsequent Therapy in Patients Presenting for Phase I Clinical Trials.Effect of Age on Survival Outcome in Operated and Non-Operated Patients with Colon Cancer: A Population-Based StudyYoung patients and gastrointestinal (GI) tract malignancies - are we addressing the unmet needs?Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program.Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis.AYA in the USA. International Perspectives on AYAO, Part 5.Metastatic colorectal cancer: current treatment and future options for improved survival. Medical approach--present status.Reporting of meta-analyses of randomized controlled trials with a focus on drug safety: an empirical assessment.The adolescent and young adult with cancer: state of the art--epithelial cancer.Different clinical characteristics in sporadic young-age onset colorectal cancer.A population-based study of metastatic colorectal cancer in individuals aged ≥ 80 years: findings from the South Australian Clinical Registry for Metastatic Colorectal Cancer.Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Adolescent and Young Adults with Peritoneal Metastases.
P2860
Q26824773-C8D501C2-FEE5-437C-9929-5C2C3687A662Q33940633-CDB97CE5-9861-4294-9840-BD6B90CA234DQ34695185-550F7DF8-07E1-4102-962C-1A9B51EE542FQ35132975-26D56EE6-BF5B-40AD-A832-0F2AE1F9C73EQ35632548-5DD44909-0B26-4492-AB49-12DCE676BA4EQ35899035-883E82AD-6306-4C80-AA22-CEC5A066F22FQ36103214-F75272CC-3E6D-41B7-8A59-44AD860D8946Q36733282-2188794F-A163-47A4-BFBD-7D38D2492D9FQ37115074-01F05B13-E6D1-4706-B9F2-724253E68FACQ37406641-9088A0B5-C0D8-4B19-AE7D-4C86C09F26F5Q37975508-38FD4EA9-46D5-427D-B1A1-7EFCD2E01663Q38091030-DED82D75-FA46-4361-961D-5DBD950C1971Q38113517-BB36BF2C-B277-42E0-937B-5C295146E877Q39387446-A0E3A626-2162-459F-991F-46FD896070DAQ44654735-9E8E9212-E965-46B3-92EE-E38BBC1F33BEQ52939514-ED06AEF2-9EED-4DB2-A5C5-1822C6717775
P2860
Impact of young age on treatment efficacy and safety in advanced colorectal cancer: a pooled analysis of patients from nine first-line phase III chemotherapy trials.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Impact of young age on treatme ...... phase III chemotherapy trials.
@en
type
label
Impact of young age on treatme ...... phase III chemotherapy trials.
@en
prefLabel
Impact of young age on treatme ...... phase III chemotherapy trials.
@en
P2093
P2860
P50
P356
P1476
Impact of young age on treatme ...... phase III chemotherapy trials.
@en
P2093
Archie Bleyer
Charles D Blanke
Claus-Henning Kohne
David M Thomas
Matthew T Seymour
Richard M Goldberg
P2860
P304
P356
10.1200/JCO.2010.33.5281
P407
P577
2011-06-06T00:00:00Z